Company profile: RhythMedix
1.1 - Company Overview
Company description
- Provider of cardiac diagnostics and monitoring solutions, including RhythmStar wearable ECG monitor with built-in 4G cellular connectivity for continuous monitoring and compliance checks, mobile cardiac telemetry, extended wear Holter (3–15 days), Holter monitoring (24–48 hours), event monitoring, and RhythmConnect patient portal to enroll, track, and manage patients, supported by outstanding service, support, and patient care.
Products and services
- Mobile Cardiac Telemetry: Delivers real-time cardiac monitoring by continuously capturing ECG activity, allowing for immediate detection and reporting of arrhythmias
- RhythmStar: A wearable cardiac ECG monitor with built-in 4G cellular connectivity, delivering continuous monitoring, daily compliance checks, and customizable notifications
- RhythmConnect: Offers a patient portal that allows clinicians to enroll, track, and manage patients, providing seamless integration with existing practice workflows
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to RhythMedix
Sanifit
HQ: Spain
Website
- Description: Provider of biotechnology therapies for calcification disorders, developing SNF472 in phase 3 for calciphylaxis associated with chronic kidney disease and dialysis, and for peripheral artery disease in end-stage kidney disease, aiming to reduce arterial and cardiovascular calcification; supported by the CaLIPSO phase 2b trial showing significant reduction in coronary artery calcium progression in dialysis patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sanifit company profile →
BioCardia
HQ: United States
Website
- Description: Provider of clinical-stage regenerative cardiology therapies and delivery systems, including CardiAMP autologous bone marrow cell therapy for heart failure, CardiALLO allogeneic mesenchymal stem cell therapy, the Helix system for minimally invasive biologic delivery to the heart, Morph DNA FDA-approved steerable introducer sheaths for cardiac/peripheral procedures, and the AVANCE bi-directional steerable introducer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioCardia company profile →
ATS Medical
HQ: United States
Website
- Description: Provider of cardiovascular surgery medical devices, doing business as Medtronic ATS Medical, Inc.; manufactures, markets, and distributes mechanical heart valves (including the ATS Open Pivot Heart Valve), aortic valve graft prostheses, and other cardiovascular accessories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ATS Medical company profile →
Puzzle Medical
HQ: Canada
Website
- Description: Provider of minimally invasive long-term hemodynamic transcatheter pump solutions for advanced heart failure. Offers ModulHeart, a modular percutaneous heart pump supporting cardiac and renal function via multiple pumps anchored in parallel in the descending aorta, a portable controller with a long-life battery for autonomous operation, and a bedside monitoring station for cath lab programming and monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Puzzle Medical company profile →
Bolton Medical
HQ: United States
Website
- Description: Provider of endovascular and surgical aortic repair solutions, offering thoracic and abdominal stent-graft systems and hybrid graft devices tailored to diverse anatomies. Products include Thoraflex Hybrid, TREO, Anaconda, and relayplus with dual sheath delivery for optimal aortic navigation, precision and control, repositionable deployment, and predictable placement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bolton Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for RhythMedix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to RhythMedix
2.2 - Growth funds investing in similar companies to RhythMedix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for RhythMedix
4.2 - Public trading comparable groups for RhythMedix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →